SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jacob Chacko, M.D., its Chief Financial Officer, will make a presentation at the 2016 Cantor Fitzgerald Healthcare Conference on July 13, 2016, at 1:00 p.m. Eastern time (10:00 a.m. Pacific time) in New York, NY, and will discuss Ignyta’s novel Rx/Dx approach and review recent updates from ongoing clinical trials of the company’s robust pipeline of molecularly targeted therapies.
